InternationalUSRemember you can easily switch between MIP US and MIP International at any time

In-house IP roundup – Generics say SPC Waiver will save money but increase litigation, counsel share M&A tips



Patrick Wingrove, London


Patent Strategy, a new service from Managing IP, rounds up the latest news and analysis from patent-focused businesses

SPC man

Generics: SPC Waiver will save money but increase litigation

Fresenius Kabi, Insud Pharma and other generic drug firms explain how the EU’s SPC manufacturing waiver in its compromised form will benefit them – but also how its notification clause could make litigation easier and more attractive to innovator drug companies. (Read more … )

chain

In-house counsel share M&A due diligence tips

Uber, Nestlé and a luggage company speak to Patent Strategy about their due diligence difficulties during mergers and acquisitions and how they avoid the inherent portfolio analysis pitfalls. (Read more … )

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.


Comments






More from the Managing IP blog


null null null

nullnullnull

null

May / June 2019

From trademarks to trade secrets: in-house tips on brand protection in China

Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies



Most read articles

Supplements